Celldex Therapeutics (CLDX) Gross Margin (2010 - 2026)
Celldex Therapeutics (CLDX) posted quarterly Gross Margin of 9620.0% for Q1 2026, down 940806.0% year-over-year from N/an in Q1 2025, and down 951.51% quarter-over-quarter from 914.88% in Q4 2025.
Powered by 
Analysis
Celldex Therapeutics (CLDX) Gross Margin (2010 - 2026) Analysis & Trends
Celldex Therapeutics' Gross Margin history runs 7 years deep, the most recent figure standing at 9620.0% for Q1 2026.
- In Q1 2026, Gross Margin fell 940806.0% year-over-year to 9620.0%; the TTM figure through Mar 2026 stood at 510.51% (down 52490.0% YoY), while the FY2025 annual figure was 288.16%, down 30823.0% from the prior year.
- Gross Margin for Q1 2026 stood at 9620.0%, down from 914.88% in the prior quarter.
- The five-year high for Gross Margin was 66.34% in Q3 2024, with the low at 9620.0% in Q1 2026.
- The 3-year median for Gross Margin is 161.72% (2025), against an average of 1441.56%.
- The sharpest annual moves came in 2025 and 2026: Gross Margin soared 52652 bps in 2025, then slumped 940806 bps in 2026.
- Celldex Therapeutics' Gross Margin stood at 37.36% in 2024, then slumped by 2349 bps to 914.88% in 2025, then slumped by 952 bps to 9620.0% in 2026.
- Business Quant data shows CLDX's Gross Margin at 9620.0% in Q1 2026, 914.88% in Q4 2025, and 111.51% in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 85.33% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 91.59% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 90.43% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 35.86% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 89.76% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 76.90% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 84.20% |
| 10 | Celldex Therapeutics | 3.10 Bn | 3.10 Bn | -2.57 Mn | -11,686.36% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -11,686.36% |
| Mar 31, 2026 | -9,620.00% |
| Dec 31, 2025 | -914.88% |
| Jun 30, 2025 | -111.51% |
| Mar 31, 2025 | -211.94% |
| Dec 31, 2024 | -37.36% |
| Sep 30, 2024 | 66.34% |
| Jun 30, 2024 | 35.35% |
| Mar 31, 2024 | -738.46% |
| Dec 31, 2013 | 100.00% |
| Sep 30, 2013 | 100.00% |
| Jun 30, 2013 | 100.00% |
| Mar 31, 2013 | 3.31% |
| Dec 31, 2012 | 2.63% |
| Sep 30, 2012 | 3.44% |
| Jun 30, 2012 | 6.77% |
| Mar 31, 2012 | 3.66% |
| Dec 31, 2011 | 3.08% |
| Sep 30, 2011 | 1.90% |
| Jun 30, 2011 | 0.56% |